STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 38 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $952,000 | -31.3% | 466,863 | -0.0% | 0.00% | – |
| Q2 2021 | $1,386,000 | -30.5% | 466,879 | -35.4% | 0.00% | – |
| Q1 2021 | $1,995,000 | +42.0% | 723,069 | +25.0% | 0.00% | – |
| Q4 2020 | $1,405,000 | +16.5% | 578,424 | +0.6% | 0.00% | – |
| Q3 2020 | $1,206,000 | -40.5% | 574,780 | +7.1% | 0.00% | – |
| Q2 2020 | $2,028,000 | +101.8% | 536,700 | +0.9% | 0.00% | – |
| Q1 2020 | $1,005,000 | -39.3% | 532,094 | -32.9% | 0.00% | – |
| Q4 2019 | $1,656,000 | +95.5% | 793,208 | +123.7% | 0.00% | – |
| Q3 2019 | $847,000 | +25.9% | 354,584 | +64.7% | 0.00% | – |
| Q2 2019 | $673,000 | +261.8% | 215,290 | +474.6% | 0.00% | – |
| Q1 2019 | $186,000 | -44.3% | 37,467 | -50.0% | 0.00% | – |
| Q4 2018 | $334,000 | +84.5% | 74,934 | +100.0% | 0.00% | – |
| Q3 2018 | $181,000 | -19.6% | 37,467 | -0.4% | 0.00% | – |
| Q2 2018 | $225,000 | -74.7% | 37,628 | -62.6% | 0.00% | – |
| Q1 2018 | $889,000 | +55.1% | 100,525 | +27.1% | 0.00% | – |
| Q4 2017 | $573,000 | +26.8% | 79,093 | +20.7% | 0.00% | – |
| Q3 2017 | $452,000 | +3.7% | 65,539 | +7.3% | 0.00% | – |
| Q2 2017 | $436,000 | +514.1% | 61,063 | +306.8% | 0.00% | – |
| Q1 2017 | $71,000 | – | 15,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |